Who this procedure is for

Focal hip cartilage damage confirmed on MRI, combined with a documented attempt at conservative care that has not provided adequate relief, is the standard entry point for this procedure. The most common indication is Kellgren–Lawrence Grade III or IV hip osteoarthritis — including patients described clinically as 'bone on bone' — though there is no fixed cartilage-defect threshold, since ChondroFiller coats the joint surface rather than filling a precisely bounded cavity.

ChondroFiller itself is an injectable collagen scaffold: a purified Type I collagen matrix that is introduced into the hip joint under real-time ultrasound guidance, adapts to the contours of the worn surface, and gels in place within minutes to provide a cushioning layer that supports the body's own repair processes. Because the material is acellular — containing no living donor cells — no tissue biopsy or cell harvest from the patient is required before the appointment. The pathway is an outpatient image-guided injection in a clinic room, not a surgical procedure.

At Lincolnshire Hip the appointment is available without a GP referral. The stated price of £2,995 covers the consultation, real-time ultrasound, the ChondroFiller product, IV antibiotic prophylaxis, and a six-week follow-up.

What to arrange before the appointment

Arranging a lift home is the single practical step that cannot be left to the day itself. Local anaesthetic delivered to the hip region can cause temporary numbness or weakness in the leg, so driving after the appointment is not permitted — a companion who can take the patient home and remain available for the first few hours is non-negotiable.

In the days before attending, contact the clinical team if you take anticoagulant medication — including Warfarin, Rivaroxaban, Apixaban, Aspirin, or Clopidogrel — or if there is any recent history of DVT, current antibiotic use, or known medication allergies. Any of these may require the appointment to be rescheduled or the clinical approach adjusted, so flagging them early avoids a last-minute delay on the day.

Wear loose, comfortable clothing that allows easy access to the hip area without the need to undress completely. It is also worth confirming with the clinic ahead of time that your pre-procedure MRI scans have been received and are on file.

No fasting or hospital pre-admission preparation is required — this is a clinic-room outpatient appointment, not a theatre booking.

From check-in to local anaesthetic

The appointment begins simply: a member of the clinical team verifies identity, confirms the procedure consent, and pulls up the pre-procedure MRI images. Reviewing those scans before a needle is placed is not a formality — it allows the treating clinician to confirm the exact location and extent of the cartilage damage so that the injection can be directed precisely where it is needed.

Once that review is complete, the patient is asked to change into a gown and a nurse records baseline observations — blood pressure, heart rate, and oxygen saturation — which are monitored throughout the appointment.

Preparing the hip for injection follows a standard aseptic sequence. The skin over the entry site is cleaned with an antiseptic solution and sterile draping is applied to the surrounding area, minimising infection risk before the needle enters the joint. IV antibiotic prophylaxis is also administered at this stage, providing infection cover as part of the standard appointment package.

A small numbing injection — the local anaesthetic — is the final step before the procedure itself. Applied to the skin and superficial tissue at the entry point, it works in the same way a dentist numbs the treatment area before dental work. There is no general anaesthetic and no sedation; the patient remains awake throughout. Most find the preparation phase unremarkable, and the local anaesthetic takes effect quickly, so discomfort during the injection that follows is minimal.

The ultrasound-guided injection itself

The actual injection begins once the local anaesthetic has taken effect. With the patient positioned and the hip skin prepared, the clinician places an ultrasound probe against the skin — this produces a live image on a bedside screen, showing the structures inside the hip joint in real time. That continuous picture allows the clinician to steer the needle tip with precision, navigating around the blood vessels and nerves that run close to the joint before arriving at the focal cartilage defect confirmed on the pre-procedure MRI.

ChondroFiller — the acellular Type I collagen liquid — is then delivered through that needle directly to the target site. Because it is an off-the-shelf, cell-free scaffold (no tissue has been harvested or prepared in advance), the liquid can be placed straight into the fluid joint environment without first drying the joint or debriding the defect surface. This is a meaningful practical difference from arthroscopic delivery routes, which require additional steps before the material can be secured in place.

What happens next takes only minutes. The collagen liquid immediately conforms to the contours of the cartilage damage and self-sets into a dimensionally stable hydrogel within three to five minutes of entering the joint — no suturing, no fixation, no further intervention. This rapid in-situ gelling is what makes the outpatient injection route clinically viable: the scaffold anchors itself.

Over the weeks that follow, the hydrogel acts as a structural matrix for acellular matrix-induced chondrogenesis — a process in which the patient's own progenitor cells migrate into the collagen scaffold and support the body's own repair processes, rather than the product itself replacing lost cartilage from scratch.

The active injection phase, from needle placement to withdrawal, typically takes between 15 and 30 minutes.

Recovery in clinic and the journey home

Once the needle is withdrawn, the procedure room work is done. Most patients move to a nearby recovery area and rest for one to two hours — a precautionary wait while the local anaesthetic wears off and the clinical team confirms there is no adverse reaction to the injection. For the majority of patients, this period is unremarkable: there is no wound to dress, no dressing to check, and no hospital ward to be transferred to. The appointment has never left the clinic.

It is normal to notice some aching, localised swelling, or stiffness around the hip during those first hours. This is the hip's response to needle entry and collagen placement, not a sign that anything has gone wrong. Paracetamol and ibuprofen, taken regularly for the first two to three days if needed, are usually sufficient to manage this phase.

Once the team is satisfied that observations are stable and the local anaesthetic has worn off adequately, you are discharged home the same day — your companion drives you back, since residual leg numbness makes driving unsafe.

Before you leave, a six-week follow-up appointment is arranged, giving the clinical team a fixed point to review your progress and assess how the collagen scaffold is settling in.

What to expect in the weeks and months ahead

Improvement after a ChondroFiller hip injection is gradual rather than immediate. The collagen scaffold takes time to integrate and support the body's own repair processes, and most patients begin to notice meaningful gains in hip function and pain reduction somewhere between two and six months after the procedure — not in the first days or weeks. Patients who judge the result at the four-week mark may underestimate what is still under way.

The published evidence across hip, knee, and small-joint applications offers a useful reference range: around 70–85% of treated patients achieve meaningful symptom relief at three to five years. For the hip specifically, published studies record an improvement of approximately 30 points on the modified Harris Hip Score (mHHS) — a clinically significant shift in pain, mobility, and daily function. These figures are drawn from real data, not a promise about any individual outcome.

Long-term durability beyond five years remains an area where evidence is still accumulating, and standardised injection-specific protocols for the hip are still being developed across the field. Stating that plainly is not a reason to discount the procedure — the results published to date are consistent — but it is information that belongs in any honest account of what to expect.

That uncertainty is also precisely why individual assessment matters. A consultation can map the available evidence against one person's MRI findings, hip function, and goals in a way that a general outcomes figure cannot. Lincolnshire Hip accepts patients without a GP referral, with appointments available in Sleaford and Grantham.